BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 22975871)

  • 1. Antiviral immune responses by human langerhans cells and dendritic cells in HIV-1 infection.
    van den Berg LM; Geijtenbeek TB
    Adv Exp Med Biol; 2013; 762():45-70. PubMed ID: 22975871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans Cell-Dendritic Cell Cross-Talk via Langerin and Hyaluronic Acid Mediates Antigen Transfer and Cross-Presentation of HIV-1.
    van den Berg LM; Cardinaud S; van der Aar AM; Sprokholt JK; de Jong MA; Zijlstra-Willems EM; Moris A; Geijtenbeek TB
    J Immunol; 2015 Aug; 195(4):1763-73. PubMed ID: 26170391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptor usage dictates HIV-1 restriction by human TRIM5α in dendritic cell subsets.
    Ribeiro CM; Sarrami-Forooshani R; Setiawan LC; Zijlstra-Willems EM; van Hamme JL; Tigchelaar W; van der Wel NN; Kootstra NA; Gringhuis SI; Geijtenbeek TB
    Nature; 2016 Dec; 540(7633):448-452. PubMed ID: 27919079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Langerin is a natural barrier to HIV-1 transmission by Langerhans cells.
    de Witte L; Nabatov A; Pion M; Fluitsma D; de Jong MA; de Gruijl T; Piguet V; van Kooyk Y; Geijtenbeek TB
    Nat Med; 2007 Mar; 13(3):367-71. PubMed ID: 17334373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of two temporal phases of HIV-1 transfer from primary Langerhans cells to T cells: the role of langerin.
    Nasr N; Lai J; Botting RA; Mercier SK; Harman AN; Kim M; Turville S; Center RJ; Domagala T; Gorry PR; Olbourne N; Cunningham AL
    J Immunol; 2014 Sep; 193(5):2554-64. PubMed ID: 25070850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Langerhans cells in innate defense against pathogens.
    de Jong MA; Geijtenbeek TB
    Trends Immunol; 2010 Dec; 31(12):452-9. PubMed ID: 21030306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct roles for DC-SIGN+-dendritic cells and Langerhans cells in HIV-1 transmission.
    de Witte L; Nabatov A; Geijtenbeek TB
    Trends Mol Med; 2008 Jan; 14(1):12-9. PubMed ID: 18055263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human immunodeficiency virus-1 acquisition in genital mucosa: Langerhans cells as key-players.
    de Jong MA; Geijtenbeek TB
    J Intern Med; 2009 Jan; 265(1):18-28. PubMed ID: 19093957
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutz-3-derived Langerhans cells are a model to study HIV-1 transmission and potential inhibitors.
    de Jong MA; de Witte L; Santegoets SJ; Fluitsma D; Taylor ME; de Gruijl TD; Geijtenbeek TB
    J Leukoc Biol; 2010 Apr; 87(4):637-43. PubMed ID: 20042470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acutely infected Langerhans cells are more efficient than T cells in disseminating HIV type 1 to activated T cells following a short cell-cell contact.
    Ayehunie S; Groves RW; Bruzzese AM; Ruprecht RM; Kupper TS; Langhoff E
    AIDS Res Hum Retroviruses; 1995 Aug; 11(8):877-84. PubMed ID: 7492434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative investigation of Langerhans' cells and potential receptors for HIV in oral, genitourinary and rectal epithelia.
    Hussain LA; Lehner T
    Immunology; 1995 Jul; 85(3):475-84. PubMed ID: 7558138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue dendritic cells as portals for HIV entry.
    Harman AN; Kim M; Nasr N; Sandgren KJ; Cameron PU
    Rev Med Virol; 2013 Sep; 23(5):319-33. PubMed ID: 23908074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpes simplex virus type 2 enhances HIV-1 susceptibility by affecting Langerhans cell function.
    de Jong MA; de Witte L; Taylor ME; Geijtenbeek TB
    J Immunol; 2010 Aug; 185(3):1633-41. PubMed ID: 20592277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Langerin functions as an antiviral receptor on Langerhans cells.
    van der Vlist M; Geijtenbeek TB
    Immunol Cell Biol; 2010; 88(4):410-5. PubMed ID: 20309013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of human dendritic cells in HIV-1 infection.
    Ahmed Z; Kawamura T; Shimada S; Piguet V
    J Invest Dermatol; 2015 May; 135(5):1225-1233. PubMed ID: 25407434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD4 coexpression regulates DC-SIGN-mediated transmission of human immunodeficiency virus type 1.
    Wang JH; Janas AM; Olson WJ; KewalRamani VN; Wu L
    J Virol; 2007 Mar; 81(5):2497-507. PubMed ID: 17151103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral mucosal expression of HIV-1 receptors, co-receptors, and alpha-defensins: tableau of resistance or susceptibility to HIV infection?
    Cutler CW; Jotwani R
    Adv Dent Res; 2006 Apr; 19(1):49-51. PubMed ID: 16672549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycodendrimers prevent HIV transmission via DC-SIGN on dendritic cells.
    Garcia-Vallejo JJ; Koning N; Ambrosini M; Kalay H; Vuist I; Sarrami-Forooshani R; Geijtenbeek TB; van Kooyk Y
    Int Immunol; 2013 Apr; 25(4):221-33. PubMed ID: 23291968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infection of dendritic cells (DCs), not DC-SIGN-mediated internalization of human immunodeficiency virus, is required for long-term transfer of virus to T cells.
    Burleigh L; Lozach PY; Schiffer C; Staropoli I; Pezo V; Porrot F; Canque B; Virelizier JL; Arenzana-Seisdedos F; Amara A
    J Virol; 2006 Mar; 80(6):2949-57. PubMed ID: 16501104
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DC-SIGN-mediated infectious synapse formation enhances X4 HIV-1 transmission from dendritic cells to T cells.
    Arrighi JF; Pion M; Garcia E; Escola JM; van Kooyk Y; Geijtenbeek TB; Piguet V
    J Exp Med; 2004 Nov; 200(10):1279-88. PubMed ID: 15545354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.